Effects of high frequency exercise in patients before and after elective percutaneous coronary intervention

被引:36
|
作者
Back, Maria [1 ]
Wennerblom, Bertil [2 ]
Wittboldt, Susanna [1 ]
Cider, Asa [1 ,2 ]
机构
[1] Sahlgrens Univ Hosp, Dept Phys Therapy, S-41345 Gothenburg, Sweden
[2] Univ Gothenburg, Inst Med, Dept Metab & Cardiovasc Res, Gothenburg, Sweden
关键词
Coronary artery disease; Angina pectoris; Percutaneous transluminal coronary angioplasty; Exercise; Physical endurance; Quality of life;
D O I
10.1016/j.ejcnurse.2008.02.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of this study was to evaluate the effects of high frequency exercise for patients before and after an elective Percutaneous coronary intervention (PCI), with special reference to maximal aerobic capacity, muscle function, health related quality of life (HRQoL), waist-hip ratio (WHR) and restenosis. Methods: A randomised, controlled study was performed in Sweden between 2004 and 2006 in thirty-seven patients (five women) with stable coronary artery disease (CAD), age 63.6 +/- 6.9 years, randomised to either high frequency exercise or control group. The patients in the training group performed three endurance resistance exercises and trained on a cycle ergometer 30 min, 5 times a week for 8 months at 70% Of VO2max. Results: Patients in the training group significantly improved their maximal aerobic capacity (15 (9-46) vs. 8 (0-18)% p <= 0.05), shoulder flexion (p <= 0.01), shoulder abduction (p <= 0.01) and heel-lift (p <= 0.05) compared to the control group. There were no significant differences between the groups in HRQoL, WHR and restenosis. Conclusion: High frequency exercise in patients treated with PCI seems to improve maximal aerobic capacity and muscle function, which may reduce the risks of further progression of atherosclerosis. However, further larger studies are needed to fully investigate the effects of exercise in patients with PCI. (C) 2008 European Society of Cardiology, Published by Elsevier B.V All rights reserved.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 50 条
  • [31] Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
    Kai Nogami
    Masahiro Hoshino
    Yoshihisa Kanaji
    Tomoyo Sugiyama
    Toru Misawa
    Masahiro Hada
    Masao Yamaguchi
    Tatsuhiro Nagamine
    Yun Teng
    Hiroki Ueno
    Kazuki Matsuda
    Kodai Sayama
    Tsunekazu Kakuta
    [J]. Scientific Reports, 12 (1)
  • [32] AFFECTION FOR ELECTIVE PERCUTANEOUS CORONARY INTERVENTION WITH HIGH DOSE CLOPIDOGREL
    Wang ShiHong
    Xu Aibin
    Wang Xi
    Wang Shihong
    [J]. HEART, 2013, 99 : E163 - E164
  • [33] Early Clinical and Echocardiographic Effects of Elective Percutaneous Coronary Intervention
    Amin, Mohamed
    El Hosieny, Rania
    Ragab, Dalia
    Wadie, Ashraf
    [J]. LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2011, 8 (04): : 1068 - 1077
  • [34] Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
    Nogami, K.
    Hoshino, M.
    Kanaji, Y.
    Sugiyama, T.
    Misawa, T.
    Hada, M.
    Yamaguchi, M.
    Nagamine, T.
    Teng, Y.
    Ueno, H.
    Matsuda, K.
    Sayama, K.
    Kakuta, T.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 292 - 292
  • [35] Enoxaparin in elective percutaneous coronary intervention
    Bhala, Neeraj
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26): : 2788 - 2788
  • [36] Frequency of high bleeding risk in patients undergoing percutaneous coronary intervention
    Mahmood, Muhammad Muzaffar
    Eajaz, Farwa
    Hussain, Aasif
    Zahid, Arva
    Saeed, Kiran
    Rehman, Junaid
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (09) : 2186 - 2191
  • [37] Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention
    Shehata, M.
    [J]. MINERVA CARDIOANGIOLOGICA, 2014, 62 (06): : 461 - 471
  • [38] Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
    Alkhalil, Mohammad
    Dzavik, Vladimir
    Bhatt, Deepak L.
    Mehran, Roxana
    Mehta, Shamir R.
    [J]. CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 277 - 293
  • [39] The use of cardiovascular medications in patients with coronary artery disease before and after percutaneous coronary intervention
    Tangsucharit, P.
    Samkaew, T.
    Laowachirasuwan, C.
    Jantaruechai, S.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (05): : E56 - E56
  • [40] Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
    Mohammad Alkhalil
    Vladimír Džavík
    Deepak L. Bhatt
    Roxana Mehran
    Shamir R. Mehta
    [J]. Current Cardiology Reports, 2022, 24 : 277 - 293